MED12 and uterine corpus leiomyoma: To determine whether the transcriptomic profiles of tissue samples from myometria of non-fibroid patients (M) and from myometria of MED12mt fibroid patients (MF), are comparable and/or distinct from each other and uterine fibroids, we performed RNA-seq analysis of tissue samples from M (n = 6), MF (n = 6) and MED12-mutant fibroids (F) (n = 6).